Essential Thrombocythemia Market to Witness Upsurge in Growth by 2032, Predicts DelveInsight | Key Companies to Look Out - Imago BioSciences, Incyte, Karyopharm, Novartis, PharmaEssentia, Celgene, Kartos, Sierra Oncology
LAS VEGAS, Aug. 30, 2023 /PRNewswire/ -- DelveInsight's Essential Thrombocythemia Market Insights report includes a comprehensive understanding of current treatment practices, essential thrombocythemia emerging drugs, market share of individual therapies, and current and forecasted market size from 2019 to 2032, segmented into 7MM [the United States, the EU-4 (Italy, Spain, France, and Germany), the United Kingdom, and Japan].
- These factors along with the expected launch of emerging therapies will boost the essential thrombocythemia market in the forecasted period.
- As per DelveInsight analysts, total prevalent population of essential thrombocythemia in the 7MM was 240K in 2020.
- Estimates observed that the age-group 60-80 years accounted for highest cases of essential thrombocythemia in the United States.
- To know more about essential thrombocythemia treatment, visit @ Essential Thrombocythemia Treatment Drugs